Table 3.
Linear regression analysis to identify the association between risk factors and the number of JCSLs.
| Variable | Crude β (95% CI) | P | Adjusted β (95% CI)a | P |
|---|---|---|---|---|
| Serum 25(OH)D3 | 0.004 (−0.015–0.023) | 0.687 | −0.003 (−0.022–0.016) | 0.733 |
| Low-density lipoprotein cholesterol | 0.172 (−0.289–0.633) | 0.461 | 0.120 (−0.345–0.585) | 0.610 |
| ApoB | 0.446 (−0.566–1.457) | 0.384 | 0.406 (−0.634–1.446) | 0.440 |
| ApoB/apoA | 0.256 (−1.025–1.537) | 0.692 | 0.230 (−1.080–1.541) | 0.728 |
| HCY | 0.094 (0.013–0.175) | 0.023 | 0.103 (0.021–0.185) | 0.015 |
JCSLs, juxtacortical small lesions; ρ, correlation coefficent; P, P value; 25(OH)D3, 25-hydroxyvitamin D3; LDL, low-density lipoprotein; HDL, high-densitylipoprotein apoB, apolipoprotein B; apoA, apolipoprotein A; HCY, homocysteine.
aAdjusted for age, sex, DM, HBP, and Mini-Mental State Examination score.
The reference of sex, DM, and HBP categories are man, no DM, and no HBP relatively.
The bold font of numbers refer to P < 0.05.